Chronic lymphocytic leukemia (CLL) is a chronic incurable mature B-cell neoplasm that often does not require immediate treatment; however, when patients experience symptoms, such as anemia, cytopenias, or bulky lymphadenopathy, therapy is required. During a presentation at the 2022 Oncology Nurse Advisor Summit, Laura J. Zitella, MS, RN, ACNP-BC, AOCN, an associate clinical professor at…
A review of approved treatments for non-small cell lung cancer focused on targetable driver mutations.
A presentation at the ONA Summit reviewed the cancer screening guidelines from the ACS and USPSTF.
Diagnosis, goals of care, and treatment options for MDS are discussed in a presentation at 2022 ONA Summit.
Several guidelines outline best practice for monitoring patients receiving immune checkpoint inhibitors, how to detect the early signs of these adverse events, and how to manage the events.
Dr Faiman explains the disease trajectory of R/R MM and strategies for managing patient care.
An overview of immunotherapy and the most significant adverse events nurses should monitor for in patients undergoing treatment with these novel agents.
The estimated incidence rate of new breast cancer in 2022 will be roughly 290,560 people across all stages and types of breast cancer.
Here is a preview of the topics and sessions available at this year’s Summit with a link to the registration page.
